Dr. Claudio Scuoppo is Head of Biology at Lime Therapeutics. Prior to joining Lime, Claudio was Associate Director of Immuno-oncology at Sapience Therapeutics, where he developed preclinical models and immuno-oncology assays for clinical-stage therapeutics. His academic background includes positions at Columbia University Medical Center and Cold Spring Harbor Laboratory, focused on drug repurposing and tumor suppressor biology in hematologic malignancies, with publications in Nature, PNAS, and Blood Cancer Discovery. Claudio holds a Ph.D. in Cancer Biology from Cold Spring Harbor Laboratory and is the recipient of awards from the Leukemia & Lymphoma Society and the American Society of Hematology.